[DPHARMA] QoQ Cumulative Quarter Result on 31-Dec-2021 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
15-Feb-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
31-Dec-2021 [#4]
Profit Trend
QoQ- 31.45%
YoY- 12.07%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 544,757 367,683 185,941 639,175 493,731 321,893 166,454 120.27%
PBT 69,504 48,119 26,646 82,983 65,856 43,373 23,176 107.82%
Tax -16,553 -11,517 -6,355 -17,300 -15,889 -10,369 -5,562 106.76%
NP 52,951 36,602 20,291 65,683 49,967 33,004 17,614 108.15%
-
NP to SH 52,951 36,602 20,291 65,683 49,967 33,004 17,614 108.15%
-
Tax Rate 23.82% 23.93% 23.85% 20.85% 24.13% 23.91% 24.00% -
Total Cost 491,806 331,081 165,650 573,492 443,764 288,889 148,840 121.68%
-
Net Worth 647,522 634,375 621,987 621,564 612,147 614,350 635,424 1.26%
Dividend
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Div 4,761 4,734 - 21,660 4,708 3,530 - -
Div Payout % 8.99% 12.93% - 32.98% 9.42% 10.70% - -
Equity
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Net Worth 647,522 634,375 621,987 621,564 612,147 614,350 635,424 1.26%
NOSH 952,239 952,239 941,765 941,765 941,765 706,330 706,026 22.05%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 9.72% 9.95% 10.91% 10.28% 10.12% 10.25% 10.58% -
ROE 8.18% 5.77% 3.26% 10.57% 8.16% 5.37% 2.77% -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 57.21 38.83 20.03 67.87 52.43 45.58 23.58 80.46%
EPS 5.59 3.88 2.19 6.98 5.31 4.67 2.49 71.36%
DPS 0.50 0.50 0.00 2.30 0.50 0.50 0.00 -
NAPS 0.68 0.67 0.67 0.66 0.65 0.87 0.90 -17.03%
Adjusted Per Share Value based on latest NOSH - 941,765
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 56.63 38.22 19.33 66.45 51.33 33.46 17.30 120.30%
EPS 5.50 3.81 2.11 6.83 5.19 3.43 1.83 108.12%
DPS 0.49 0.49 0.00 2.25 0.49 0.37 0.00 -
NAPS 0.6731 0.6595 0.6466 0.6462 0.6364 0.6387 0.6606 1.25%
Price Multiplier on Financial Quarter End Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 -
Price 1.30 1.20 1.49 1.68 1.81 3.03 2.75 -
P/RPS 2.27 3.09 7.44 2.48 3.45 6.65 11.66 -66.37%
P/EPS 23.38 31.04 68.17 24.09 34.11 64.83 110.23 -64.40%
EY 4.28 3.22 1.47 4.15 2.93 1.54 0.91 180.45%
DY 0.38 0.42 0.00 1.37 0.28 0.17 0.00 -
P/NAPS 1.91 1.79 2.22 2.55 2.78 3.48 3.06 -26.94%
Price Multiplier on Announcement Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 09/11/22 16/08/22 17/05/22 15/02/22 18/11/21 17/08/21 03/05/21 -
Price 1.39 1.34 1.51 1.60 1.62 2.49 2.93 -
P/RPS 2.43 3.45 7.54 2.36 3.09 5.46 12.43 -66.28%
P/EPS 25.00 34.66 69.08 22.94 30.53 53.28 117.44 -64.31%
EY 4.00 2.88 1.45 4.36 3.28 1.88 0.85 180.55%
DY 0.36 0.37 0.00 1.44 0.31 0.20 0.00 -
P/NAPS 2.04 2.00 2.25 2.42 2.49 2.86 3.26 -26.81%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment